| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
80 A carboxypeptidase inhibitor markedly improves the potency of tPA in-vivo
|
|
|
1998
|
|
S1 |
p. 29-
1 p.
|
artikel
|
| 2 |
206 A clot — target anticoagulant
|
|
|
1998
|
|
S1 |
p. 75-
1 p.
|
artikel
|
| 3 |
131 Activation of procarboxypeptidase U, an enzyme involved in the regulation of fibrinolysis
|
|
|
1998
|
|
S1 |
p. 46-
1 p.
|
artikel
|
| 4 |
198 A de novo spontaneous point mutation found in a Brazilian patient with antithrombin deficiency
|
|
|
1998
|
|
S1 |
p. 73-
1 p.
|
artikel
|
| 5 |
100 Adhesion and integrin signaling in the human kidney epithelial cell line TCL-598 are modulated by the urokinase receptor in a matrix dependent fashion
|
|
|
1998
|
|
S1 |
p. 36-
1 p.
|
artikel
|
| 6 |
77 Affinity of lipoprotein(a) for cell and fibrin is modulated by apo(a) size
|
|
|
1998
|
|
S1 |
p. 28-
1 p.
|
artikel
|
| 7 |
50 A 30,000 g/mol protein involved in plasminogen activation in the dextran sulphate euglobulin fraction of human plasma depleted in both t-PA and u-PA
|
|
|
1998
|
|
S1 |
p. 19-
1 p.
|
artikel
|
| 8 |
259 All-trans retinoic acid (ATRA) inhibits the fibrinolytic capacity of blood mononuclear cells
|
|
|
1998
|
|
S1 |
p. 96-
1 p.
|
artikel
|
| 9 |
138 A method for determination of t-PA activity in rat
|
|
|
1998
|
|
S1 |
p. 49-
1 p.
|
artikel
|
| 10 |
97 A model to explain the mechanism of stimulation of tPA activity by cell surface receptors
|
|
|
1998
|
|
S1 |
p. 35-
1 p.
|
artikel
|
| 11 |
12 A monoclonal antibody inducing the substrate form of PAI-1 has antithrombotic activity in rat models of venous and arterial thrombosis
|
|
|
1998
|
|
S1 |
p. 6-
1 p.
|
artikel
|
| 12 |
68 A monoclonal antibody (MAB) to fibrin. Delineation of the epitope on the COOH terminal of the Aα-chain and its use in a soluble fibrin assay
|
|
|
1998
|
|
S1 |
p. 25-
1 p.
|
artikel
|
| 13 |
40 A mutant of plasminogen activator inhibitor type-2 (PAI-2) that is less prone to form loop-sheet polymers
|
|
|
1998
|
|
S1 |
p. 16-
1 p.
|
artikel
|
| 14 |
74 Analysis of fibrin degradation products by multi-angle laser light scattering: A model for fibrin degradation
|
|
|
1998
|
|
S1 |
p. 27-
1 p.
|
artikel
|
| 15 |
142 Analytical evaluation of four D-dimer tests
|
|
|
1998
|
|
S1 |
p. 50-
1 p.
|
artikel
|
| 16 |
37 An ester bond linking a fragment of the serine proteinase uPA to its serpin inhibitor PAI-1
|
|
|
1998
|
|
S1 |
p. 15-
1 p.
|
artikel
|
| 17 |
72 A new highly sensitive rapid sandwich ELISA assay for the determination of blood coagulation factor XIII in human plasma
|
|
|
1998
|
|
S1 |
p. 26-
1 p.
|
artikel
|
| 18 |
53 A new mutation (Val384Met) in the human plasmin inhibitor gene associated with plasmin inhibitor deficiency and bleeding tendency
|
|
|
1998
|
|
S1 |
p. 20-
1 p.
|
artikel
|
| 19 |
69 A new test for measuring soluble fibrin in plasma with a high predictive value for thrombotic disorders
|
|
|
1998
|
|
S1 |
p. 25-
1 p.
|
artikel
|
| 20 |
252 Angiostatin fragments in urine from patients with malignant disease
|
|
|
1998
|
|
S1 |
p. 93-
1 p.
|
artikel
|
| 21 |
168 Anticardiolipin antibodies are associated with monocytes, metabolic and fibrinolytic parameters in young women with a history of myocardial infarction
|
|
|
1998
|
|
S1 |
p. 60-
1 p.
|
artikel
|
| 22 |
130 Antifibrinolytic versus profibrinolytic functions of histidine-rich glycoprotein
|
|
|
1998
|
|
S1 |
p. 46-
1 p.
|
artikel
|
| 23 |
6 Antigenic modulation of recombinant staphylokinase by comprehensive site-directed mutagenesis
|
|
|
1998
|
|
S1 |
p. 4-
1 p.
|
artikel
|
| 24 |
164 Antigen plasma levels of total and free tissue factor pathway inhibitor in hypercholesterolemia
|
|
|
1998
|
|
S1 |
p. 58-
1 p.
|
artikel
|
| 25 |
143 Antiplasmin and plasminogen on STA and STA Compact, evaluated
|
|
|
1998
|
|
S1 |
p. 51-
1 p.
|
artikel
|
| 26 |
169 Antithrombin and thrombolytic agents does not prevent platelet activation in heparin-induced thrombocytopenic syndromes
|
|
|
1998
|
|
S1 |
p. 61-
1 p.
|
artikel
|
| 27 |
8 Antithrombin prevents endotoxin-induced hypotension in rats by inhibiting excess production of nitric oxide
|
|
|
1998
|
|
S1 |
p. 5-
1 p.
|
artikel
|
| 28 |
Antithrombotic treatment for the preservation and enhancement of myocardial perfusion in chronic coronary artery disease
|
Leschke, M.
|
|
1997
|
|
S1 |
p. 119-123
5 p.
|
artikel
|
| 29 |
115 APC resistance and fibrinolysis abnormalities in thrombophilic patients
|
|
|
1998
|
|
S1 |
p. 41-
1 p.
|
artikel
|
| 30 |
19 Associations of PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction. The PRIME study
|
|
|
1998
|
|
S1 |
p. 9-
1 p.
|
artikel
|
| 31 |
Atherosclerosis, thrombosis and inflammation: a problem of linkage
|
Tracy, R.P.
|
|
1997
|
|
S1 |
p. 137-141
5 p.
|
artikel
|
| 32 |
73 Atomic force microscopy of fibrin networks and plasma clots during fibrinolysis
|
|
|
1998
|
|
S1 |
p. 27-
1 p.
|
artikel
|
| 33 |
Author index
|
|
|
1998
|
|
S1 |
p. 99-104
6 p.
|
artikel
|
| 34 |
140 Auto-Dimer, a new method for the measurement of D-dimer
|
|
|
1998
|
|
S1 |
p. 50-
1 p.
|
artikel
|
| 35 |
31 Basic fibroblast growth factor, urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 in lung cancer cells
|
|
|
1998
|
|
S1 |
p. 13-
1 p.
|
artikel
|
| 36 |
Bezafibrate following acute myocardial infarction: important findings from the bezafibrate coronary atherosclerosis intervention trial
|
Nilsson, J.
|
|
1997
|
|
S1 |
p. 159-162
4 p.
|
artikel
|
| 37 |
2 cDNA and gene structure of rat plasminogen
|
|
|
1998
|
|
S1 |
p. 3-
1 p.
|
artikel
|
| 38 |
184 Cellular degradation of free and PAI-1-bound t-PA. Requirement for a co-receptor?
|
|
|
1998
|
|
S1 |
p. 67-
1 p.
|
artikel
|
| 39 |
193 Cellular localization of urokinase-type plasminogen activator, its inhibitors and their mRNAs in breast cancer tissues
|
|
|
1998
|
|
S1 |
p. 70-
1 p.
|
artikel
|
| 40 |
240 Changes in PAI-1, factor VII and fibrinogen by hormone replacement therapy are independent of promoter polymorphisms
|
|
|
1998
|
|
S1 |
p. 89-
1 p.
|
artikel
|
| 41 |
202 Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulation
|
|
|
1998
|
|
S1 |
p. 74-
1 p.
|
artikel
|
| 42 |
183 Characterization of plasminogen receptor expression on NB4 promyelocytic cells
|
|
|
1998
|
|
S1 |
p. 67-
1 p.
|
artikel
|
| 43 |
197 Characterization of the binding of a pentapeptide to plasminogen activator inhibitor -1
|
|
|
1998
|
|
S1 |
p. 72-
1 p.
|
artikel
|
| 44 |
25 Characterization of the gene encoding human TAFI
|
|
|
1998
|
|
S1 |
p. 11-
1 p.
|
artikel
|
| 45 |
172 Climax and hormonal substitute therapy (HST)
|
|
|
1998
|
|
S1 |
p. 62-
1 p.
|
artikel
|
| 46 |
212 Clinical laboratory monitoring of a synthetic antithrombin agent, argatroban, using HPLC and functional methods
|
|
|
1998
|
|
S1 |
p. 78-
1 p.
|
artikel
|
| 47 |
180 Clonning and expression of a new recombinant staphylokinase variant
|
|
|
1998
|
|
S1 |
p. 65-
1 p.
|
artikel
|
| 48 |
176 Coagulation activation markers in the diagnosis of deep vein thrombosis following total hip replacement
|
|
|
1998
|
|
S1 |
p. 63-
1 p.
|
artikel
|
| 49 |
243 Combined heterozygous deficiency of factor V and plasminogen in the same kindred
|
|
|
1998
|
|
S1 |
p. 90-
1 p.
|
artikel
|
| 50 |
126 Comparision the influence of different alpha adrenoreceptor antagonists on the fibrinolysis system
|
|
|
1998
|
|
S1 |
p. 45-
1 p.
|
artikel
|
| 51 |
123 Comparison of Actilyse and Reteplase by lysine binding and enzyme behaviour
|
|
|
1998
|
|
S1 |
p. 43-
1 p.
|
artikel
|
| 52 |
137 Comparison of a new rapid bedside assay for t-PA with a commercially available ELISA: Possible importance of t-PA antigen determination during thrombolytic therapy for predicition of outcome
|
|
|
1998
|
|
S1 |
p. 49-
1 p.
|
artikel
|
| 53 |
211 Comparison of tests for the measurement of C-reactive protein in the low range
|
|
|
1998
|
|
S1 |
p. 77-
1 p.
|
artikel
|
| 54 |
235 Comparison of the biological activities of chitosan polysulphate, unfractionated heparin and mixture of this substances after intravenous application
|
|
|
1998
|
|
S1 |
p. 87-
1 p.
|
artikel
|
| 55 |
26 Comparison of the structures of thrombomodulin required for the activation of protein C and TAFI
|
|
|
1998
|
|
S1 |
p. 11-
1 p.
|
artikel
|
| 56 |
196 Complex-formation of PAI-1 with tPA. Findings supporting full insertion of reactive-centre loop into β-sheet A
|
|
|
1998
|
|
S1 |
p. 71-
1 p.
|
artikel
|
| 57 |
Coronary artery disease and inflammation: reflection of underlying disease or repetitive ischemia
|
Liuzzo, G.
|
|
1997
|
|
S1 |
p. 155-157
3 p.
|
artikel
|
| 58 |
92 Corticosteroids and insulin affect PAI-1 synthesis by human adipose tissue
|
|
|
1998
|
|
S1 |
p. 33-
1 p.
|
artikel
|
| 59 |
C-reactive protein and cardiovascular disease
|
Haverkate, F.
|
|
1997
|
|
S1 |
p. 133-134
2 p.
|
artikel
|
| 60 |
4 Crystal structure of TSV-PA: A new plasminogen activator from snake venom
|
|
|
1998
|
|
S1 |
p. 4-
1 p.
|
artikel
|
| 61 |
66 Cyclic nucleotide regulation of plasminogen activator-inhibitor mRNA stability in rat hepatoma cells: identification of cis-acting sequences
|
|
|
1998
|
|
S1 |
p. 24-
1 p.
|
artikel
|
| 62 |
104 Detection of a PAI-1 gene allele variant possibly associated with decreased plasma levels of PAI-1 in four patients with bleeding tendency
|
|
|
1998
|
|
S1 |
p. 37-
1 p.
|
artikel
|
| 63 |
213 Detection of impaired platelet function during thrombolysis by PFA-100 platelet function analyzer
|
|
|
1998
|
|
S1 |
p. 78-
1 p.
|
artikel
|
| 64 |
257 Detection of tPA in human and mouse mast cells
|
|
|
1998
|
|
S1 |
p. 95-
1 p.
|
artikel
|
| 65 |
148 Disseminated intravascular coagulation, fibrinolysis-and proteolysis-syndrome (DIC-F-P-S) in two patients (PTS) with purulent cholangitis or portal sepsis, complicated with acute hepatic failure (AHF). Benefit from therapy with plasma derivates (PD) (AT IIIc, FFP)
|
|
|
1998
|
|
S1 |
p. 53-
1 p.
|
artikel
|
| 66 |
179 Does exact indication prevent hemorrhagic complications using streptokinase in acute ischemic stroke?
|
|
|
1998
|
|
S1 |
p. 65-
1 p.
|
artikel
|
| 67 |
17 Donor-Donor energy migration (DDEM) for determining intramolecular distances in latent plasminogen activator inhibitor type 1 (PAI-1)
|
|
|
1998
|
|
S1 |
p. 8-
1 p.
|
artikel
|
| 68 |
157 Effect of a low osmolality nonionic contrast medium on thrombin generation and fibrinolysis in patients subjected to coronary angiography
|
|
|
1998
|
|
S1 |
p. 56-
1 p.
|
artikel
|
| 69 |
129 Effect of arginines 320 and 330 of TAFI on the thermal stability of the enzyme — a thermodynamic interpretation
|
|
|
1998
|
|
S1 |
p. 46-
1 p.
|
artikel
|
| 70 |
112 Effect of heparin and hirudin on endotoxin-induced PAI-1 mRNA expression by human umbilical vein endothelial cells
|
|
|
1998
|
|
S1 |
p. 40-
1 p.
|
artikel
|
| 71 |
59 Effect of intravenous defibrotide treatment on soluble P-selectin, soluble thrombomodulin and PAI-1 levels
|
|
|
1998
|
|
S1 |
p. 22-
1 p.
|
artikel
|
| 72 |
28 Effect of TAFI activation on clot lysis by pharmacological concentrations of t-PA
|
|
|
1998
|
|
S1 |
p. 12-
1 p.
|
artikel
|
| 73 |
9 Effect of unfractionated heparin and a heparin pentasaccharide on the thrombolytic process in an experimental model in rabbits
|
|
|
1998
|
|
S1 |
p. 5-
1 p.
|
artikel
|
| 74 |
227 Effects of recombinant human erytropoietin (rHuEPO) on the fibrinolytic system in peritoneal dialysis (PD) patients
|
|
|
1998
|
|
S1 |
p. 84-
1 p.
|
artikel
|
| 75 |
224 Elevated PAI-1 and F1.2 levels in children with Escherichia coli O157:H7 related hemolytic uremic syndrome
|
|
|
1998
|
|
S1 |
p. 83-
1 p.
|
artikel
|
| 76 |
Endogenous fibrinolytic function and risks of future myocardial infarction and stroke: observations from the Physicians' Health Study
|
Ridker, P.M.
|
|
1997
|
|
S1 |
p. 55-59
5 p.
|
artikel
|
| 77 |
76 Enhanced fibrinolytic capacity of α2-antiplasmin-deficient mice
|
|
|
1998
|
|
S1 |
p. 28-
1 p.
|
artikel
|
| 78 |
18 Evaluation of the mechanism of inactivation of plasminogen activator inhibitor-1 by monoclonal antibodies using a stable variant
|
|
|
1998
|
|
S1 |
p. 8-
1 p.
|
artikel
|
| 79 |
Experiments on the risk factor role of fibrinogen
|
Born, G.V.R.
|
|
1997
|
|
S1 |
p. 9-12
4 p.
|
artikel
|
| 80 |
44 Expression of PAI-1 in normal and atherosclerotic vessels in an experimental model of angioplasty in pigs
|
|
|
1998
|
|
S1 |
p. 17-
1 p.
|
artikel
|
| 81 |
118 Expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiation
|
|
|
1998
|
|
S1 |
p. 42-
1 p.
|
artikel
|
| 82 |
36 Expression of plasminogen-related gene B varies among normal tissues and increases in cancer tissues
|
|
|
1998
|
|
S1 |
p. 14-
1 p.
|
artikel
|
| 83 |
182 Expression of prolebetase from Vipera lebetina by baculovirus system. Plasminogen activating activity of SF-9 cell lysates
|
|
|
1998
|
|
S1 |
p. 66-
1 p.
|
artikel
|
| 84 |
165 Factor VIIa, plasminogen activator inhibitor-1, thrombomodulin and vWF levels in patients with arterial disease and patients with risk factors for arterial disease
|
|
|
1998
|
|
S1 |
p. 59-
1 p.
|
artikel
|
| 85 |
219 Failure of antiplatelet effectiveness of low-dose ASA in essential thrombocytaemia
|
|
|
1998
|
|
S1 |
p. 81-
1 p.
|
artikel
|
| 86 |
20 Fibrin D-dimer, C-reactive protein and risk of ischaemic heart disease: The Speedwell Study
|
|
|
1998
|
|
S1 |
p. 9-
1 p.
|
artikel
|
| 87 |
178 Fibrin D-dimer levels in a pregnant woman homozygous for FV Leiden
|
|
|
1998
|
|
S1 |
p. 64-
1 p.
|
artikel
|
| 88 |
Fibrinogen and atherosclerosis: a study in transgenic mice
|
Koopman, J.
|
|
1997
|
|
S1 |
p. 19-21
3 p.
|
artikel
|
| 89 |
204 Fibrinogen-heparin interaction. Biochemical and functional importance
|
|
|
1998
|
|
S1 |
p. 75-
1 p.
|
artikel
|
| 90 |
Fibrinogen mediates vasoactive effects in saphenous vein by an ICAM-1 dependent pathway
|
Hicks, R.C.J.
|
|
1997
|
|
S1 |
p. 27-29
3 p.
|
artikel
|
| 91 |
220 Fibrinolysis in female with malignant diseases: Ca mammae et Ca cervicis uteri
|
|
|
1998
|
|
S1 |
p. 81-
1 p.
|
artikel
|
| 92 |
93 Fibrinolytic activity, functional fibrinogen and triglycerides in insulin dependent diabetes mellitus
|
|
|
1998
|
|
S1 |
p. 33-
1 p.
|
artikel
|
| 93 |
159 Fibrinolytic activity in patients with myocardial infarction
|
|
|
1998
|
|
S1 |
p. 57-
1 p.
|
artikel
|
| 94 |
162 Fibrinolytic activity in preterm and full-term neonates
|
|
|
1998
|
|
S1 |
p. 58-
1 p.
|
artikel
|
| 95 |
203 Fibrinolytic complex of heparin with glutamic acid
|
|
|
1998
|
|
S1 |
p. 74-
1 p.
|
artikel
|
| 96 |
216 Fibrinolytic disturbances in chronic myeloid leukaemia
|
|
|
1998
|
|
S1 |
p. 80-
1 p.
|
artikel
|
| 97 |
226 Fibrinolytic parameters are not risk factors for developing restenosis after recanalisation procedures in peripheral arteries
|
|
|
1998
|
|
S1 |
p. 83-
1 p.
|
artikel
|
| 98 |
133 Fibrinolytic properties of activated factor XII
|
|
|
1998
|
|
S1 |
p. 47-
1 p.
|
artikel
|
| 99 |
158 Fibrinolytic response to venous occlusion compared to exercise stress in young patients with coronary artery disease and healthy controls
|
|
|
1998
|
|
S1 |
p. 56-
1 p.
|
artikel
|
| 100 |
23 Fibrinolytic variables as predictors of restenosis after PTCA
|
|
|
1998
|
|
S1 |
p. 10-
1 p.
|
artikel
|
| 101 |
79 Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro
|
|
|
1998
|
|
S1 |
p. 29-
1 p.
|
artikel
|
| 102 |
190 Focal increase in tPA activity and extracellular proteolysis were observed prior to neuronal cell death in the hippocampus after kainic acid injection
|
|
|
1998
|
|
S1 |
p. 69-
1 p.
|
artikel
|
| 103 |
Foreword
|
Koenig, W
|
|
1997
|
|
S1 |
p. 1-
1 p.
|
artikel
|
| 104 |
223 Fraxiparine administration in pregnants with cardiac pathology and thrombophilia
|
|
|
1998
|
|
S1 |
p. 82-
1 p.
|
artikel
|
| 105 |
222 Fraxiparine in treatment of chronic DIC-syndrome in patients with EPH-gestosis
|
|
|
1998
|
|
S1 |
p. 82-
1 p.
|
artikel
|
| 106 |
102 Functional consequences of the up-modulation of plasminogen receptors on leukocytes
|
|
|
1998
|
|
S1 |
p. 36-
1 p.
|
artikel
|
| 107 |
135 Functional role of soluble cell adhesion molecules (sCAM) in atherosclerosis
|
|
|
1998
|
|
S1 |
p. 48-
1 p.
|
artikel
|
| 108 |
244 -455 G/A fibrinogen promoter polymorphism and Cytomegalovirus infection modulate fibrinogen levels but not the risk of premature coronary heart disease
|
|
|
1998
|
|
S1 |
p. 90-
1 p.
|
artikel
|
| 109 |
Gene-environment interaction in the determination of plasma levels of fibrinogen
|
Humphries, S.E.
|
|
1997
|
|
S1 |
p. 3-7
5 p.
|
artikel
|
| 110 |
250 Gene expression of fibrinolytic factors in regenerating mice liver
|
|
|
1998
|
|
S1 |
p. 93-
1 p.
|
artikel
|
| 111 |
32 Genetherapy with adenovirus expressing ATF-BPTI hybrid protein inhibits proteolysis by rheumatoid synovial fibroblasts
|
|
|
1998
|
|
S1 |
p. 13-
1 p.
|
artikel
|
| 112 |
105 Genetic determinant on PAI-1 levels: A study in twins
|
|
|
1998
|
|
S1 |
p. 37-
1 p.
|
artikel
|
| 113 |
Haemostatic system and arterial disease: future perspectives
|
Meade, T.W.
|
|
1997
|
|
S1 |
p. 167-171
5 p.
|
artikel
|
| 114 |
177 Hemocoagulative alterations in patients with acute myocardial infarction and in relatives: comparison with healthy individuals
|
|
|
1998
|
|
S1 |
p. 63-
1 p.
|
artikel
|
| 115 |
54 Hemostaseologic and molecular genetic studies in four patients with severe type I plasminogen (Plg) deficiency and ligneous conjunctivitis
|
|
|
1998
|
|
S1 |
p. 20-
1 p.
|
artikel
|
| 116 |
258 Hepatocyte growth factor (HGF) stimulates plasminogen activator inhibitor-1 (PAI-1) and vascular endothelial growth factor (VEGF) in human keratinocytes and KDR in human endothelial cells in vitro
|
|
|
1998
|
|
S1 |
p. 95-
1 p.
|
artikel
|
| 117 |
147 Heterogeneous distribution of the subclass IgG anti-streptokinase antibodies
|
|
|
1998
|
|
S1 |
p. 53-
1 p.
|
artikel
|
| 118 |
24 High Lp(a) levels: Possible risk factor for restenosis after PTCA
|
|
|
1998
|
|
S1 |
p. 10-
1 p.
|
artikel
|
| 119 |
Homocysteine, atherogenesis and thrombosis
|
Harpel, P.C.
|
|
1997
|
|
S1 |
p. 77-80
4 p.
|
artikel
|
| 120 |
How does hyperfibrinogenemia lead to thrombosis?
|
McDonagh, J.
|
|
1997
|
|
S1 |
p. 13-17
5 p.
|
artikel
|
| 121 |
How to detect activated coagulation
|
Bauer, K.A.
|
|
1997
|
|
S1 |
p. 23-26
4 p.
|
artikel
|
| 122 |
255 Human mast cells express functional uPAR/CD87
|
|
|
1998
|
|
S1 |
p. 94-
1 p.
|
artikel
|
| 123 |
1 Human plasminogen kringle 2: Ligand binding properties and NMR solution structure
|
|
|
1998
|
|
S1 |
p. 3-
1 p.
|
artikel
|
| 124 |
Hyperfibrinogenemia and cardiovascular risk: possible strategies for intervention
|
Koenig, W.
|
|
1997
|
|
S1 |
p. 41-46
6 p.
|
artikel
|
| 125 |
Hyperinsulinemia increases plasma activity of PAI-1 in vivo independently of an acute phase reaction
|
Nordt, T.K.
|
|
1997
|
|
S1 |
p. 51-54
4 p.
|
artikel
|
| 126 |
229 Hypofibrinolysis in patients with thrombosis or recurrent miscarriages
|
|
|
1998
|
|
S1 |
p. 84-
1 p.
|
artikel
|
| 127 |
237 Hypoplasminogenemia and factor V Leiden defect in a family with thrombotic tendency
|
|
|
1998
|
|
S1 |
p. 88-
1 p.
|
artikel
|
| 128 |
111 Identification and localization of protein C inhibitor (PCI) in resting platelets
|
|
|
1998
|
|
S1 |
p. 39-
1 p.
|
artikel
|
| 129 |
199 Identification of two novel splice site mutations responsible for type I antithrombin deficiency
|
|
|
1998
|
|
S1 |
p. 73-
1 p.
|
artikel
|
| 130 |
III TAFI (procarboxypeptidase b) compared to the other inhibitors of the fibrinolytic system
|
|
|
1998
|
|
S1 |
p. 1-
1 p.
|
artikel
|
| 131 |
II Tissue plasminogen activator and plasminogen in the brain
|
|
|
1998
|
|
S1 |
p. 1-
1 p.
|
artikel
|
| 132 |
110 Immunofluorescence analysis of t-PA in human endothelial cells
|
|
|
1998
|
|
S1 |
p. 39-
1 p.
|
artikel
|
| 133 |
117 Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women
|
|
|
1998
|
|
S1 |
p. 41-
1 p.
|
artikel
|
| 134 |
57 Impaired fibrinolysis associated to FV R506Q mutation in patients with a history of atherothrombotic stroke
|
|
|
1998
|
|
S1 |
p. 21-
1 p.
|
artikel
|
| 135 |
55 Impaired release of tissue-type plasminogen activator (t-PA) from vascular endothelium in essential hypertension
|
|
|
1998
|
|
S1 |
p. 21-
1 p.
|
artikel
|
| 136 |
156 Impairment of fibrinolysis after PTCA and restenosis
|
|
|
1998
|
|
S1 |
p. 56-
1 p.
|
artikel
|
| 137 |
242 Incidence of factor V Leiden and the prothrombin variant 20210 G→A in the Navarrese population: Preliminary studies in a group of Navarrese patients with venous thrombosis
|
|
|
1998
|
|
S1 |
p. 89-
1 p.
|
artikel
|
| 138 |
186 Increased fibrinolytic gene expression in pulmonary artery
|
|
|
1998
|
|
S1 |
p. 68-
1 p.
|
artikel
|
| 139 |
174 Increased PAI-1 levels and venous thromboembolism
|
|
|
1998
|
|
S1 |
p. 62-
1 p.
|
artikel
|
| 140 |
201 Increased tissue factor and tissue factor pathway inhibitor levels in the lungs of idiopathic pulmonary fibrosis patients associated with elevated procoagulant activity
|
|
|
1998
|
|
S1 |
p. 74-
1 p.
|
artikel
|
| 141 |
64 Induction of type-1 plasminogen activator inhibitor (PAI-1) gene expression by thiazolidinediones during adipocyte differentiation
|
|
|
1998
|
|
S1 |
p. 24-
1 p.
|
artikel
|
| 142 |
101 Induction of tyrosine phosphorylation by the interaction of tissue-type plasminogen activator (t-PA) and its receptor (t-PAR) in human endothelial cells
|
|
|
1998
|
|
S1 |
p. 36-
1 p.
|
artikel
|
| 143 |
192 Induction of urokinase-type plasminogen activator by oxidative stress in RC-K8 Human pre-B lymphoma cells
|
|
|
1998
|
|
S1 |
p. 70-
1 p.
|
artikel
|
| 144 |
Infection, hemostatic factors and cardiovascular disease
|
Khaw, K.T.
|
|
1997
|
|
S1 |
p. 149-153
5 p.
|
artikel
|
| 145 |
Inflammation in atherosclerotic plaques: a clinically crucial event
|
van der Wal, A.C.
|
|
1997
|
|
S1 |
p. 125-128
4 p.
|
artikel
|
| 146 |
Inflammation: the protein C pathway
|
Esmon, C.T.
|
|
1997
|
|
S1 |
p. 143-148
6 p.
|
artikel
|
| 147 |
Inflammatory markers as predictors in unstable angina
|
de Maat, M.P.M.
|
|
1997
|
|
S1 |
p. 135-136
2 p.
|
artikel
|
| 148 |
185 Influence of vasopressin analogues on plasminogen activator release
|
|
|
1998
|
|
S1 |
p. 67-
1 p.
|
artikel
|
| 149 |
11 Infusion of anti-PAI-1 monoclonal antibodies to rabbits given endotoxin to induce DIC
|
|
|
1998
|
|
S1 |
p. 6-
1 p.
|
artikel
|
| 150 |
173 Inherited thrombophillia and pregnancy — high risk combination for thrombosis
|
|
|
1998
|
|
S1 |
p. 62-
1 p.
|
artikel
|
| 151 |
215 INR results from 4 prothrombin time (PT) reagents, using different reference times, compared
|
|
|
1998
|
|
S1 |
p. 79-
1 p.
|
artikel
|
| 152 |
121 Interaction of plasminogen and tPA with immobilised enolase studied by surface plasmon resonance (SPR)
|
|
|
1998
|
|
S1 |
p. 43-
1 p.
|
artikel
|
| 153 |
89 Interactions between stromelysin-1 (MMP-3) and the plasminogen/urokinase-type plasminogen activator (u-PA) system
|
|
|
1998
|
|
S1 |
p. 32-
1 p.
|
artikel
|
| 154 |
5 Interface scanning and 3D model of the staphylokinase:plasmin activator complex
|
|
|
1998
|
|
S1 |
p. 4-
1 p.
|
artikel
|
| 155 |
254 Intracellular signaling in retinoic-induced NB4 cell differentiation and fibrinolysis regulation
|
|
|
1998
|
|
S1 |
p. 94-
1 p.
|
artikel
|
| 156 |
48 In vivo evidence for a role of coagulation factor XI as an anti-fibrinolytic factor in a rabbit jugular vein thrombosis model
|
|
|
1998
|
|
S1 |
p. 18-
1 p.
|
artikel
|
| 157 |
231 Is tranexamic acid a therapeutic possibility for recurrent bleeding from colonic angiodysplastic lesions in hemodialysis patients ?
|
|
|
1998
|
|
S1 |
p. 85-
1 p.
|
artikel
|
| 158 |
I The current role of thrombolytic therapy in clinical practice
|
|
|
1998
|
|
S1 |
p. 1-
1 p.
|
artikel
|
| 159 |
IV Metalloproteases in remodeling of the extracellular matrix
|
|
|
1998
|
|
S1 |
p. 2-
1 p.
|
artikel
|
| 160 |
228 Lack of correlation between fibrinolytic capacity and vascular recanalization in deep vein thrombosis
|
|
|
1998
|
|
S1 |
p. 84-
1 p.
|
artikel
|
| 161 |
163 Laparascopic cholecistectomy: Thrombosis prophylaxis with low molecular weight heparin (LMWH)
|
|
|
1998
|
|
S1 |
p. 58-
1 p.
|
artikel
|
| 162 |
94 Leukocyte and plasma PAs and PAIs in major sepsis
|
|
|
1998
|
|
S1 |
p. 34-
1 p.
|
artikel
|
| 163 |
30 Levels of carboxypeptidase B (thrombin-activatable fibrinolysis inhibitor: TAFI) following thrombolysis with streptokinase
|
|
|
1998
|
|
S1 |
p. 12-
1 p.
|
artikel
|
| 164 |
153 Lifestyle and other risk factors and fibrinolytic risk factors for ischaemic heart disease: The Caerphilly Study
|
|
|
1998
|
|
S1 |
p. 55-
1 p.
|
artikel
|
| 165 |
116 Lipoprotein(a) [Lp(a)]levels and isoforms and fibrinolytic activity in postmenopause. Influence of hormone replacement therapy (HRT)
|
|
|
1998
|
|
S1 |
p. 41-
1 p.
|
artikel
|
| 166 |
260 Lipoprotein(a) phenotypes display differences in the expression of PAI-1 mRNA in human brain microvessel endothelial cells
|
|
|
1998
|
|
S1 |
p. 96-
1 p.
|
artikel
|
| 167 |
Lipoproteins and inflammation in atherosclerosis
|
Nilsson, J.
|
|
1997
|
|
S1 |
p. 129-132
4 p.
|
artikel
|
| 168 |
84 Local fibrinolytic treatment in 163 patients with acute ischemia of lower limb
|
|
|
1998
|
|
S1 |
p. 30-
1 p.
|
artikel
|
| 169 |
109 Local insulin infusion stimulates the expression of plasminogen activator inhibitor-1 and tissue plasminogen activator in normal subjects
|
|
|
1998
|
|
S1 |
p. 39-
1 p.
|
artikel
|
| 170 |
125 Localization of the human antistreptokinase IgG epitopes on streptokinase
|
|
|
1998
|
|
S1 |
p. 44-
1 p.
|
artikel
|
| 171 |
13 Loop insertion propels acylation and enhances recognition of tPA by PAI-1
|
|
|
1998
|
|
S1 |
p. 7-
1 p.
|
artikel
|
| 172 |
22 Low grade inflammation, fibrinolysis, and evolution of future coronary heart disease in initially healthy men and women
|
|
|
1998
|
|
S1 |
p. 10-
1 p.
|
artikel
|
| 173 |
Lp(a) lipoprotein and risk of atherosclerotic/thrombotic disease
|
Berg, K.
|
|
1997
|
|
S1 |
p. 71-75
5 p.
|
artikel
|
| 174 |
98 Mapping contact areas of uPA/inhibitor complexes and receptor-associated-protein with endocytosis receptors by the use of monoclonal antibodies and genetically and proteolytically modified ligands and receptors
|
|
|
1998
|
|
S1 |
p. 35-
1 p.
|
artikel
|
| 175 |
170 Markers of thrombophilia in symptomatic and asymptomatic carriers of homozygous factor V Leiden
|
|
|
1998
|
|
S1 |
p. 61-
1 p.
|
artikel
|
| 176 |
127 Mathematic model of fibrin clot lysis by plasmin
|
|
|
1998
|
|
S1 |
p. 45-
1 p.
|
artikel
|
| 177 |
87 Matrix metalloproteinase expression after vascular injury in mice
|
|
|
1998
|
|
S1 |
p. 31-
1 p.
|
artikel
|
| 178 |
Mechanisms for thrombolysis-induced increases in procoagulant and proinflammatory activity
|
Schaiff, W.T.
|
|
1997
|
|
S1 |
p. 115-118
4 p.
|
artikel
|
| 179 |
7 Melagatran, a novel thrombin inhibitor, reduces renal and haemodynamic effects of endotoxin in the pig
|
|
|
1998
|
|
S1 |
p. 5-
1 p.
|
artikel
|
| 180 |
205 Menaquinone types of vitamin K (MK-4 and MK-7) increased after ingestion of phylloquinone foods
|
|
|
1998
|
|
S1 |
p. 75-
1 p.
|
artikel
|
| 181 |
58 Mild hyperhomocysteinemia and fibrinolytic factors in patients with history of venous thromboembolism
|
|
|
1998
|
|
S1 |
p. 22-
1 p.
|
artikel
|
| 182 |
85 MMP-9 and MMP-2 activities in stomach and breast tumours, as measured by a novel MMP activity assay using modified urokinase as a substrate
|
|
|
1998
|
|
S1 |
p. 31-
1 p.
|
artikel
|
| 183 |
Molecular markers of hemostasis and fibrinolysis and inhibitor levels in unstable angina pectoris
|
Hoffmeister, H.M.
|
|
1997
|
|
S1 |
p. 61-65
5 p.
|
artikel
|
| 184 |
27 Molecular mass dependence and the effect of TAFIa on the t-PA and DSPA cofactor activities of soluble fibrin degradation products
|
|
|
1998
|
|
S1 |
p. 11-
1 p.
|
artikel
|
| 185 |
141 Monoclonal antibodies specific for D-dimer
|
|
|
1998
|
|
S1 |
p. 50-
1 p.
|
artikel
|
| 186 |
47 Monocyte chemotactic protein 1 (MCP-1) accelerates thrombus resolution
|
|
|
1998
|
|
S1 |
p. 18-
1 p.
|
artikel
|
| 187 |
67 Multicentric evaluation of a new test for the quantification of D-dimer: STA-liatest D-Di
|
|
|
1998
|
|
S1 |
p. 25-
1 p.
|
artikel
|
| 188 |
262 Multiple transcripts for apolipoprotein(a)-related gene II generated by alternative splicing in tissue- and cell type-specific manners
|
|
|
1998
|
|
S1 |
p. 97-
1 p.
|
artikel
|
| 189 |
214 Near patient fibrinogen assay for monitoring ancrod treatment of ischemic stroke
|
|
|
1998
|
|
S1 |
p. 78-
1 p.
|
artikel
|
| 190 |
New antithrombotic agents: an overview
|
Windstetter, U.
|
|
1997
|
|
S1 |
p. 85-96
12 p.
|
artikel
|
| 191 |
New developments in thrombolytic therapy
|
Bode, C.
|
|
1997
|
|
S1 |
p. 109-114
6 p.
|
artikel
|
| 192 |
167 Nitric oxide and fibrinolytic system in sepsis
|
|
|
1998
|
|
S1 |
p. 59-
1 p.
|
artikel
|
| 193 |
154 No effect of wheat grain supplementation in diet on blood fibrinolysis in subjects with metabolic cardiovascular syndrome
|
|
|
1998
|
|
S1 |
p. 55-
1 p.
|
artikel
|
| 194 |
78 On the mechanism of fibrin-induced down-regulation of PAI-2 production by monocytes
|
|
|
1998
|
|
S1 |
p. 28-
1 p.
|
artikel
|
| 195 |
146 Open heart surgery and the platelet function measured with PFA-100®
|
|
|
1998
|
|
S1 |
p. 52-
1 p.
|
artikel
|
| 196 |
91 PAI-1 antigen production by human adipose tissue is correlated with that of TNFα
|
|
|
1998
|
|
S1 |
p. 33-
1 p.
|
artikel
|
| 197 |
246 PAI-1 4G/5G polymorphism and deep venous thrombosis in factor V Leiden patients
|
|
|
1998
|
|
S1 |
p. 91-
1 p.
|
artikel
|
| 198 |
103 PAI-1 promoter polymorphism and elevated PAI-1 circulating levels in postmenopausal women with coronary artery disease
|
|
|
1998
|
|
S1 |
p. 37-
1 p.
|
artikel
|
| 199 |
33 PAI-1 regulates adhesion of fibrosarcoma cells by promoting internalisation of uPAR/uPA/PAI-1 complexes
|
|
|
1998
|
|
S1 |
p. 13-
1 p.
|
artikel
|
| 200 |
90 Pathological consequences associated with altered expression of components of the plasminogen system in bleomycin induced pulmonary fibrosis
|
|
|
1998
|
|
S1 |
p. 32-
1 p.
|
artikel
|
| 201 |
Pathophysiology of acute ischemic syndromes: recent progress
|
Kristensen, S.D.
|
|
1997
|
|
S1 |
p. 105-108
4 p.
|
artikel
|
| 202 |
81 PEGylation of fibrolase overcomes inhibition by α2-macroglobulin
|
|
|
1998
|
|
S1 |
p. 29-
1 p.
|
artikel
|
| 203 |
96 Peritoneal concentration of TGF-β is associated with PAI-1 and increased peritoneal adhesion formation
|
|
|
1998
|
|
S1 |
p. 34-
1 p.
|
artikel
|
| 204 |
171 Phospholipid antibodies and their inhibitory effect on factor XII
|
|
|
1998
|
|
S1 |
p. 61-
1 p.
|
artikel
|
| 205 |
63 PKC-β and MAPK are required for the synthesis of PAI-1 during the phorbol ester-mediated adhesion of the human cell line HL-60
|
|
|
1998
|
|
S1 |
p. 23-
1 p.
|
artikel
|
| 206 |
Plasma fibrinogen and wall thickness in carotid and femoral arteries: findings from the KIHD study
|
Salonen, J.T.
|
|
1997
|
|
S1 |
p. 35-40
6 p.
|
artikel
|
| 207 |
160 Plasma PAI-1 and its release from platelets is related to the reduced platelet reactivity in patients with ischaemic heart disease
|
|
|
1998
|
|
S1 |
p. 57-
1 p.
|
artikel
|
| 208 |
122 Plasmin-catalyzed hydrolysis of substrates being the titrants of the enzyme active site
|
|
|
1998
|
|
S1 |
p. 43-
1 p.
|
artikel
|
| 209 |
41 Plasminogen activator inhibitor 2 (PAI-2) is cross-linked to fibrin and efficiently inhibits u-PA-mediated fibrinolysis
|
|
|
1998
|
|
S1 |
p. 16-
1 p.
|
artikel
|
| 210 |
106 Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism 4G/5G and plasma PAI-1 levels in subjects with ischaemic heart disease
|
|
|
1998
|
|
S1 |
p. 38-
1 p.
|
artikel
|
| 211 |
107 Plasminogen activator inhibitor 1 promoter: Analysis of responsive elements with respect to promoter polymorphism
|
|
|
1998
|
|
S1 |
p. 38-
1 p.
|
artikel
|
| 212 |
248 Plasminogen activators and inhibitors in blood of fetus with good obstetric outcome compared to normal neonates and hydrops fetalis
|
|
|
1998
|
|
S1 |
p. 92-
1 p.
|
artikel
|
| 213 |
151 Plasminogen activators (t-PA, u-PA) and plasminogen activator inhibitor type 1 (PAI-1) in hemodialysed patients with chronic renal failure
|
|
|
1998
|
|
S1 |
p. 54-
1 p.
|
artikel
|
| 214 |
113 Plasminogen binding and activation during cell death
|
|
|
1998
|
|
S1 |
p. 40-
1 p.
|
artikel
|
| 215 |
134 Platelet adhesion and plasmin generation on immobilized and FXIII crosslinked fibrin(ogen)
|
|
|
1998
|
|
S1 |
p. 48-
1 p.
|
artikel
|
| 216 |
144 Platelet Na+/H+ exchange and plasminogen activator inhibitor in patients with primary hypertension
|
|
|
1998
|
|
S1 |
p. 52-
1 p.
|
artikel
|
| 217 |
155 Possible relation of intraplatelet PAI-1 to 4G/5G polymorphism in patients undergoing cardiopulmonary bypass surgery
|
|
|
1998
|
|
S1 |
p. 55-
1 p.
|
artikel
|
| 218 |
175 Prekallikrein levels in populations of blood donors and patients receiving oral anticoagulants
|
|
|
1998
|
|
S1 |
p. 63-
1 p.
|
artikel
|
| 219 |
34 Preliminary study of uPAR and plasminogen activators and inhibitors in tissues from benign and ovarian cancer
|
|
|
1998
|
|
S1 |
p. 14-
1 p.
|
artikel
|
| 220 |
238 Prenatal diagnosis in a family with severe type I plasminogen (PLG) deficiency and ligneous conjunctivitis
|
|
|
1998
|
|
S1 |
p. 88-
1 p.
|
artikel
|
| 221 |
128 Procarboxypeptidase U in plasma from different animal species
|
|
|
1998
|
|
S1 |
p. 45-
1 p.
|
artikel
|
| 222 |
200 Prognostic value of ATIII in MODS
|
|
|
1998
|
|
S1 |
p. 73-
1 p.
|
artikel
|
| 223 |
236 Protective effect of a prostaglandin I2 analogue on graft liver subjected to in situ warm ischemia in porcine liver transplantation: Immunohistochemical analysis of thrombomodulin
|
|
|
1998
|
|
S1 |
p. 87-
1 p.
|
artikel
|
| 224 |
136 Proteolysis of NCAM and PSA-NCAM by the tissue plasminogen activator-plasmin system
|
|
|
1998
|
|
S1 |
p. 48-
1 p.
|
artikel
|
| 225 |
207 Purification and molecular cloning of salmobin, a thrombin-like enzyme from korean salmosa snake (Agkistrodon halys)
|
|
|
1998
|
|
S1 |
p. 76-
1 p.
|
artikel
|
| 226 |
61 Purification of a DNA binding protein that interact with the PAI-1 promoter
|
|
|
1998
|
|
S1 |
p. 23-
1 p.
|
artikel
|
| 227 |
35 Rapid auto-catalytic processing of Glu-plasminogen occurs on malignant breast cancer cell-surfaces
|
|
|
1998
|
|
S1 |
p. 14-
1 p.
|
artikel
|
| 228 |
232 Rapid clot lysis induced by local administration of tPA + Lys-plasminogen in the rabbit jugular vein thrombosis model
|
|
|
1998
|
|
S1 |
p. 86-
1 p.
|
artikel
|
| 229 |
245 Rapid genetic diagnosis for abnormal plasminogen by multiple amplification refractory mutation system (MARMS) and automated capillary electrophoresis
|
|
|
1998
|
|
S1 |
p. 90-
1 p.
|
artikel
|
| 230 |
Recent advances in hemostatic risk factors and cardiovascular diseases
|
Wu, K.K.
|
|
1997
|
|
S1 |
p. 31-34
4 p.
|
artikel
|
| 231 |
189 Redistribution of vascular APOER2 expression after vascular injury
|
|
|
1998
|
|
S1 |
p. 69-
1 p.
|
artikel
|
| 232 |
60 Reduced levels of tPA antigen and soluble thrombomodulin in patients with coronary heart disease after supplementation with omega-3 fatty acids
|
|
|
1998
|
|
S1 |
p. 22-
1 p.
|
artikel
|
| 233 |
86 Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system
|
|
|
1998
|
|
S1 |
p. 31-
1 p.
|
artikel
|
| 234 |
188 Regulation of rat and human plasminogen gene expression during acute phase
|
|
|
1998
|
|
S1 |
p. 68-
1 p.
|
artikel
|
| 235 |
209 Relationship between blood lipids and euglobulin clot lysis time evaluated by a new method
|
|
|
1998
|
|
S1 |
p. 77-
1 p.
|
artikel
|
| 236 |
120 Relationship between soluble fibrin and X-oligomer following elective PTCA
|
|
|
1998
|
|
S1 |
p. 42-
1 p.
|
artikel
|
| 237 |
43 Role of plasminogen activator inhibitor-1 in ischemia/reperfusion injury of rat liver
|
|
|
1998
|
|
S1 |
p. 17-
1 p.
|
artikel
|
| 238 |
10 Selective inhibition of factor Xa by the synthetic inhibitor DX-9065a reduces thrombotic reocclusion after lysis of jugular vein thrombosis in rabbits
|
|
|
1998
|
|
S1 |
p. 6-
1 p.
|
artikel
|
| 239 |
49 Separate and joint effect of DDAVP infusion and exercise on blood fibrinolytic activity — evidence of two different mechanisms of t-PA increase
|
|
|
1998
|
|
S1 |
p. 19-
1 p.
|
artikel
|
| 240 |
145 Shear-, coagulation- and fibrinolysis- induced cytokines expression in atherosclerosis
|
|
|
1998
|
|
S1 |
p. 52-
1 p.
|
artikel
|
| 241 |
187 Shear-stress-induced t-PA gene expression in vascular endothelium in intact human conduit vessels
|
|
|
1998
|
|
S1 |
p. 68-
1 p.
|
artikel
|
| 242 |
261 Smooth muscle cell apoptosis is one of the key mechanisms underlying aortic dilatation in congenital aortic valve malformations
|
|
|
1998
|
|
S1 |
p. 96-
1 p.
|
artikel
|
| 243 |
119 Soluble fibrin and X-oligomer levels following streptokinase therapy of acute myocardial infarction
|
|
|
1998
|
|
S1 |
p. 42-
1 p.
|
artikel
|
| 244 |
256 Some aspects of regulation of plasminogen activator and u-PAR antigens expression in U937, THP-1 and K562 cell lines
|
|
|
1998
|
|
S1 |
p. 95-
1 p.
|
artikel
|
| 245 |
Some interactions between the haemostatic system and lipids
|
Miller, G.J.
|
|
1997
|
|
S1 |
p. 67-69
3 p.
|
artikel
|
| 246 |
70 Specific ELISAs for quantitation of rat PAI-1 antigen and activity in biological samples
|
|
|
1998
|
|
S1 |
p. 26-
1 p.
|
artikel
|
| 247 |
132 Specific inhibition of Lp(a) binding to fibrin preserving plasminogen function
|
|
|
1998
|
|
S1 |
p. 47-
1 p.
|
artikel
|
| 248 |
71 Specific quantitation of thrombin inhibitors using ecarin clotting time: Application in point-of-care testing
|
|
|
1998
|
|
S1 |
p. 26-
1 p.
|
artikel
|
| 249 |
124 Standardisation of various urokinases. Effect of glycosylation on activity
|
|
|
1998
|
|
S1 |
p. 44-
1 p.
|
artikel
|
| 250 |
95 Steroids withdrawal normalize the reduced fibrinolytic capacity in renal transplant patients
|
|
|
1998
|
|
S1 |
p. 34-
1 p.
|
artikel
|
| 251 |
15 β-strand 5A of PAI-1 mediates transfer of conformational changes from the flexible joints region and α-helix F to the reactive centre loop
|
|
|
1998
|
|
S1 |
p. 7-
1 p.
|
artikel
|
| 252 |
225 Stress and fibrinolysis: blood parameters in relation to body parameters
|
|
|
1998
|
|
S1 |
p. 83-
1 p.
|
artikel
|
| 253 |
38 Structural insights into the PAI-1-uPA complex
|
|
|
1998
|
|
S1 |
p. 15-
1 p.
|
artikel
|
| 254 |
39 Structure function relationships of plasminogen activator inhibitor type-2 (PAI-2)
|
|
|
1998
|
|
S1 |
p. 15-
1 p.
|
artikel
|
| 255 |
241 Studies on fibrinolysis in homozyous type I plasminogen deficiency
|
|
|
1998
|
|
S1 |
p. 89-
1 p.
|
artikel
|
| 256 |
Subject index
|
|
|
1997
|
|
S1 |
p. 173-176
4 p.
|
artikel
|
| 257 |
233 Supression of PAI-1 activity levels in rat plasma by monoclonal antibodies
|
|
|
1998
|
|
S1 |
p. 86-
1 p.
|
artikel
|
| 258 |
150 Systemic inflammatory reaction may explain the activation of coagulation and fibrinolysis in patients with chronic renal failure (CRF)
|
|
|
1998
|
|
S1 |
p. 54-
1 p.
|
artikel
|
| 259 |
208 Targeting of the mouse protein C inhibitor gene
|
|
|
1998
|
|
S1 |
p. 76-
1 p.
|
artikel
|
| 260 |
46 Textilinins from Pseudonaja textilis textilis. Characterisation of two novel plasmin inhibitors which inhibit bleeding in an animal model
|
|
|
1998
|
|
S1 |
p. 18-
1 p.
|
artikel
|
| 261 |
65 TGF-β and HGF synergistically induce PAI-1 in rat FTO-2B hepatoma cells: Interaction of transcriptional and post-transcriptional mechanisms
|
|
|
1998
|
|
S1 |
p. 24-
1 p.
|
artikel
|
| 262 |
234 The action of Lonomia achelous caterpillars venom on some blood coagulation factors of the rabbit
|
|
|
1998
|
|
S1 |
p. 86-
1 p.
|
artikel
|
| 263 |
181 The antiplatelet and fibrinolytic activity of the simplest prolin-containing peptides
|
|
|
1998
|
|
S1 |
p. 65-
1 p.
|
artikel
|
| 264 |
166 The association of factor V Leiden and thromboembolism in patient with prosthetic heart valves
|
|
|
1998
|
|
S1 |
p. 59-
1 p.
|
artikel
|
| 265 |
114 The effect of argatroban on staphylokinase activity in the presence of endothelial cell injured by thrombin
|
|
|
1998
|
|
S1 |
p. 40-
1 p.
|
artikel
|
| 266 |
99 The effect of cell-density on the production of plasminogen activators and PAI-1 by human vascular smooth muscle cells
|
|
|
1998
|
|
S1 |
p. 35-
1 p.
|
artikel
|
| 267 |
251 The endometrial signal for endothelial cell migration is related to the u-PA system, and is modulated by ovarian steroids
|
|
|
1998
|
|
S1 |
p. 93-
1 p.
|
artikel
|
| 268 |
239 The 4G/5G genetic polymorphism of the plasminogen activator inhibitor-1 (PAI-1) promoter is not associated with the plasma PAI-1 levels in newborns
|
|
|
1998
|
|
S1 |
p. 88-
1 p.
|
artikel
|
| 269 |
108 The 4G/5G polymorphism of PAI-1 promoter gene as a risk factor for myocardial infarction: A meta-analysis approach
|
|
|
1998
|
|
S1 |
p. 38-
1 p.
|
artikel
|
| 270 |
51 The ginseng preparation Xuesaitong up-regulates plasminogen activator expression in human endothelial cells
|
|
|
1998
|
|
S1 |
p. 19-
1 p.
|
artikel
|
| 271 |
210 The global fibrinolytic capacity (GFC), a promising method for hypofibrinolytic state detection in thrombotic diseases
|
|
|
1998
|
|
S1 |
p. 77-
1 p.
|
artikel
|
| 272 |
247 The hemostatic-fibrinolytic profiles of human follicular fluid in the preovulatory phase
|
|
|
1998
|
|
S1 |
p. 92-
1 p.
|
artikel
|
| 273 |
161 The influence of plasmapheresis on dynamics of DIC-syndrome and hospital mortality in patients during acute period of myocardial infarction
|
|
|
1998
|
|
S1 |
p. 57-
1 p.
|
artikel
|
| 274 |
249 The influences of sex steroid hormones on production of fibrinolysis and anti-fibrinolysis factors in cultured human trophoblastic and endometrial cells
|
|
|
1998
|
|
S1 |
p. 92-
1 p.
|
artikel
|
| 275 |
152 The investigations in vivo and in vitro of the atherosclerosis, myocardial infarction and physical-chemical characteristics of human blood plasma
|
|
|
1998
|
|
S1 |
p. 54-
1 p.
|
artikel
|
| 276 |
195 The kinetics of tPA inhibition by C1-inhibitor in vivo and in vitro
|
|
|
1998
|
|
S1 |
p. 71-
1 p.
|
artikel
|
| 277 |
194 The limited cleavage and inactivation of PAI-1 by reptilase at high doses but not by defibrase
|
|
|
1998
|
|
S1 |
p. 71-
1 p.
|
artikel
|
| 278 |
16 The role of amino acid residues in the S2 and S3 strands in the B β-sheet for the PAI-1 stability
|
|
|
1998
|
|
S1 |
p. 8-
1 p.
|
artikel
|
| 279 |
The role of platelets in the early and late vascular responses initiated by mechanical vascular injury
|
Harker, L.A.
|
|
1997
|
|
S1 |
p. 97-103
7 p.
|
artikel
|
| 280 |
14 The variable region-1 of t-PA confers specificity for PAI-1 by facilitating catalysis, not affinity
|
|
|
1998
|
|
S1 |
p. 7-
1 p.
|
artikel
|
| 281 |
29 Thrombin-activatable fibrinolysis inhibitor slows clot lysis in rats, rabbits and dogs
|
|
|
1998
|
|
S1 |
p. 12-
1 p.
|
artikel
|
| 282 |
149 Thrombin generation, endothelial cell function and fibrinolytic potential in homozygous sickle cell disease and beta-thalassemia
|
|
|
1998
|
|
S1 |
p. 53-
1 p.
|
artikel
|
| 283 |
82 Thrombolytic activity of u-PA/t-PA chimera (K2tu-PA) evaluated with arterial type (Chandler) thrombi
|
|
|
1998
|
|
S1 |
p. 30-
1 p.
|
artikel
|
| 284 |
83 Thrombolytic properties of poorly immunogenic variants of recombinant staphylokinase
|
|
|
1998
|
|
S1 |
p. 30-
1 p.
|
artikel
|
| 285 |
139 TintElize tPA·PAI-1, a new method for the measurement of tPA·PAI-1 complexes
|
|
|
1998
|
|
S1 |
p. 49-
1 p.
|
artikel
|
| 286 |
230 Tissue plasminogen activator increased only in the hippocampus following the transient forebrain ischemia, which may be related to neuronal cell death
|
|
|
1998
|
|
S1 |
p. 85-
1 p.
|
artikel
|
| 287 |
88 Tissue remodelling in the ovary by plasminogen activators and matrix metalloproteinases: Regulation and functional role revealed by gene deficient mice
|
|
|
1998
|
|
S1 |
p. 32-
1 p.
|
artikel
|
| 288 |
56 tPA-PAI-1 complex as a risk factor for the development of a first stroke
|
|
|
1998
|
|
S1 |
p. 21-
1 p.
|
artikel
|
| 289 |
45 Transient expression of tissue plasminogen activator in the developing arterial system
|
|
|
1998
|
|
S1 |
p. 17-
1 p.
|
artikel
|
| 290 |
218 Triglyceride as predictor of both t-PA and PAI-1: Studies in non obese hypertriglyceridemic patients
|
|
|
1998
|
|
S1 |
p. 80-
1 p.
|
artikel
|
| 291 |
75 Ultrastructural location of the carboxy-terminal region of γ chains in fibrin(ogen) molecules labeled with a gold cluster cadaverine compound at crosslinking sites
|
|
|
1998
|
|
S1 |
p. 27-
1 p.
|
artikel
|
| 292 |
62 Unsaturated fatty acids increase PAI-1 expression in endothelial cells
|
|
|
1998
|
|
S1 |
p. 23-
1 p.
|
artikel
|
| 293 |
Urinary 8-EPI PGF2α: an index of oxidant stress in vivo
|
Reilly, M.P.
|
|
1997
|
|
S1 |
p. 81-84
4 p.
|
artikel
|
| 294 |
253 Urokinase plasminogen activator (u-PA) and its inhibitors (PAI-1, PAI-2) in tissue extracts of planoepithelial lung cancer
|
|
|
1998
|
|
S1 |
p. 94-
1 p.
|
artikel
|
| 295 |
191 Urokinase type plasminogen activator (u-PA) and its inhibitors (PAI-1, PAI-2) in extracts of planoepithelial larynx cancer
|
|
|
1998
|
|
S1 |
p. 69-
1 p.
|
artikel
|
| 296 |
21 Urokinase-type plasminogen activator (u-PA) and the risk of coronary events in patients with angina pectoris (AP)
|
|
|
1998
|
|
S1 |
p. 9-
1 p.
|
artikel
|
| 297 |
52 Urokinase (uPA)-mediated proteolytic and mitogenic functions in the vasculature: New facets of uPA-receptor-dependent and -independent activities
|
|
|
1998
|
|
S1 |
p. 20-
1 p.
|
artikel
|
| 298 |
Variables of the fibrinolytic system: risk indicators for CHD
|
Juhan-Vague, I.
|
|
1997
|
|
S1 |
p. 47-49
3 p.
|
artikel
|
| 299 |
221 Vitamin K in the reversal of the excessive effect of anti-vitamin K drugs
|
|
|
1998
|
|
S1 |
p. 81-
1 p.
|
artikel
|
| 300 |
217 Von Willebrand factor (vWF) and tissue plasminogen activator (t-PA) as markers of endothelial hyperfunction in hyperthyroidism
|
|
|
1998
|
|
S1 |
p. 80-
1 p.
|
artikel
|
| 301 |
Which haemostatic factors should be measured in clinical practice for the prediction of coronary risk?
|
van de Loo, J.C.W.
|
|
1997
|
|
S1 |
p. 163-165
3 p.
|
artikel
|
| 302 |
3 X-ray crystal structure of single chain human tPA and vampire bat plasminogen activator help to explain the activation mechanism of tPA
|
|
|
1998
|
|
S1 |
p. 3-
1 p.
|
artikel
|
| 303 |
42 XR5082 preferentially inhibits active PAI-1 which is linked to vitronectin
|
|
|
1998
|
|
S1 |
p. 16-
1 p.
|
artikel
|
Tijdschrift beschrijving